Ad
related to: ai drug discovery companies stocksmartinvestorsdaily.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the company entered into a strategic collaboration with Advanced Micro Devices ...
Recursion Pharmaceuticals (NASDAQ: RXRX) is pioneering a unique approach to drug discovery by leveraging AI and machine learning. The company's Recursion OS platform uses sophisticated algorithms ...
Here are some top companies currently working in the AI drug discovery space: Atomwise – Atomwise utilizes artificial intelligence to pioneer the use of deep learning algorithms for the ...
Isomorphic Labs Limited [1] is a London-based company which uses artificial intelligence for drug discovery. [ 2 ] [ 3 ] [ 4 ] Isomorphic Labs was founded by Demis Hassabis , who is the CEO. [ 5 ] [ 3 ] The company was incorporated on February 24, 2021 [ 1 ] and announced on November 4, 2021. [ 6 ]
“Absci’s groundbreaking work in AI drug discovery is a perfect fit for AMD high-performance computing solutions and software, designed for the most demanding AI workloads.” About Absci Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster.
Perhaps the most promising AI application is its potential to revolutionize medicine by accelerating the drug discovery process to deliver more effective therapies. 3 Top AI-Powered Biotech Stocks ...
Owkin is a French artificial intelligence and biotech company that aims to identify new treatments, optimize clinical trials and develop AI diagnostics. [1] [2] The company uses federated learning, a type of privacy preserving technology, to access multimodal patient data from academic institutions and hospitals to train its AI models for drug discovery, development, and diagnostics.
The company "applies DL, big data, and genomis for in silico drug discovery" for various conditions. [3] It has sought to develop AI to "identify novel drug targets for untreated diseases", and has pursued dual-purpose therapeutics, "going after a specific disease or several diseases while targeting ageing at the same time".
Ad
related to: ai drug discovery companies stocksmartinvestorsdaily.com has been visited by 10K+ users in the past month